• Leying Chen, Zhaoyu Wu, Linan Yang, Yuyun Chen, Wenhong Wang, Liting Cheng, Chong Li, Dazhao Lv, Liangyong Xia, Jia Chen, Lina Tang, L I Zhang, Shiyi Zhang, and Jie Luo.
• School of Biomedical Engineering, Shanghai Jiao Tong University, Shanghai, China.
• Transl Res. 2022 Jul 1; 245: 82-98.

AbstractHand-foot skin reaction (HFSR) is the most debilitating and prevalent side effect caused by multikinase inhibitors (MKIs) that share vascular endothelial growth factor receptor (VEGFR) as the common inhibition target, such as sorafenib, regorafenib, axitinib, etc. Though not life-threatening, HFSR can significantly deteriorate patients' quality of life and jeopardize the continuity of cancer therapy. Despite years of efforts, there are no FDA-approved treatments for HFSR and the understanding of the precise pathogenic mechanism is still limited. In this study, we hypothesized that nitric oxide has the potential therapeutic effect to reverse the toxicity caused by MKI through upregulation of several VEGF/VEGFR downstream signaling pathways. We found that glyceryl trinitrate (GTN), a nitric oxide donor, could stimulate cell proliferation, migration, and protect cells from apoptosis induced by MKIs in vitro. Local application of GTN mitigated tissue damage in a rat model, while not impacting the anti-tumor effect of the MKI in HepG2 tumor-bearing mice. Finally, GTN ointment alleviated cutaneous damages and improved quality of life in 6 HFSR patients. Our study proposed and validated the mechanism to counteract VEGFR inhibition, providing GTN as the potential treatment to MKI-induced HFSR, which may further improve the therapeutic window of various MKI based cancer therapies.Copyright © 2022 Elsevier Inc. All rights reserved.

11 keywords...

hide…